DiagnosTear Technologies Revenue

Medical Equipment Manufacturing • Rehovot, Center District, Israel • 1-10 Employees

DiagnosTear Technologies revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contacts at DiagnosTear Technologies

Amos Sommer

Chief Technology Officer

Oxana Kapitansky

Director Of Innovation

Company overview

Headquarters	10 Prof. Menachem Plaut St., Rehovot, Israel 7670609 , IL
Phone number	+972732753401
Website	bio-light.co.il
NAICS	3391
Keywords	Point Of Care Testing, Diagnosing Dry Eye Disease, Red Eye Diagnostics
Founded	2013
Employees	1-10
Socials

About DiagnosTear Technologies

DiagnosTear is a leading ophthalmic company developing and commercializing disruptive diagnostic solutions for better management of eye diseases. DiagnosTear’s TeaRx™ technology is a diagnostic platform intended for Point-of-Care Testing (POCT) of ophthalmic pathologies through multi-parameter composition analysis of the tear fluid. TeaRx™ technology is based on a minute sample of tear fluid taken with a unique, single-use, microfluidic tear collection device, followed by a semi-quantitative multi-parameter immunoassay, visual or digital readout and cloud-based analysis providing intuitive interpretation of the results. The whole procedure takes less than 10 minutes, is easy to perform and apart from the hand-held test reader (supplied by DiagnosTear), does not require sophisticated, expensive, or space-consuming instrumentation. The first CE-IVD approved test based on the TeaRx™ platform is intended for the identification and monitoring of Dry Eye Syndrome (DES), a common disorder in which there is a decline in tear production or tear quality is impaired. Moderate and severe DES may cause pain and discomfort, and impair vision quality. Some 340 million people worldwide have DES, including some 40 million in the United States. Beyond DES, DiagnosTear is developing innovative tests based on the TeaRx™ platform for additional ophthalmic indications. Among others, DiagnosTear’s pipeline tests include TeaRx™ Red Eye; The first test of its kind for differential assessment of adenoviral conjunctivitis, Herpetic Keratitis and Allergic conjunctivitis. This test is intended to be used by primary care physicians (GPs, family practitioners and pediatricians) as well as by ophthalmologists and is envisioned to allow on-site diagnosis of viral vs. allergic Red Eye and aid the physician in prescribing the optimal treatment and/or refer the patient for further examinations.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

DiagnosTear Technologies has 2 employees across 2 departments.

Departments

Number of employees

Funding Data

DiagnosTear Technologies has never raised funding before.

Frequently asked questions

DiagnosTear Technologies is located in Rehovot, Center District, IL.

You can reach DiagnosTear Technologies at +972732753401.

DiagnosTear Technologies generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

DiagnosTear Technologies has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

DiagnosTear Technologies was founded in 2013, making it 13 years old. The company has established itself as a significant player in its industry over this time.

DiagnosTear Technologies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at DiagnosTear Technologies

Amos Sommer

Chief Technology Officer

Oxana Kapitansky

Director Of Innovation

4.8

40,000 users